United Capital Financial Advisers LLC bought a new stake in Healthcare Realty Trust Incorporated (NYSE:HR – Get Rating) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,286 shares of the real estate investment trust’s stock, valued at approximately $340,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Trust & Banking Corp increased its stake in Healthcare Realty Trust by 6,657.5% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 221,983 shares of the real estate investment trust’s stock valued at $4,629,000 after purchasing an additional 218,698 shares during the last quarter. California Public Employees Retirement System increased its stake in Healthcare Realty Trust by 90.4% in the second quarter. California Public Employees Retirement System now owns 636,707 shares of the real estate investment trust’s stock valued at $17,318,000 after purchasing an additional 302,352 shares during the last quarter. Global Retirement Partners LLC increased its stake in Healthcare Realty Trust by 919.0% in the third quarter. Global Retirement Partners LLC now owns 2,140 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 1,930 shares during the last quarter. Treasurer of the State of North Carolina acquired a new position in Healthcare Realty Trust in the third quarter valued at $3,388,000. Finally, ProShare Advisors LLC increased its stake in Healthcare Realty Trust by 49.7% in the third quarter. ProShare Advisors LLC now owns 67,006 shares of the real estate investment trust’s stock valued at $1,397,000 after purchasing an additional 22,240 shares during the last quarter. 98.37% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on the company. Barclays lowered their price target on Healthcare Realty Trust from $33.00 to $28.00 in a research report on Thursday, November 10th. Credit Suisse Group downgraded Healthcare Realty Trust from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $23.00 to $20.00 in a research report on Monday. TheStreet downgraded Healthcare Realty Trust from a “c” rating to a “d+” rating in a research report on Wednesday, March 1st. JPMorgan Chase & Co. lowered their price target on Healthcare Realty Trust from $28.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday, December 2nd. Finally, Citigroup downgraded Healthcare Realty Trust from a “buy” rating to a “neutral” rating and lowered their price target for the company from $22.50 to $22.00 in a research report on Wednesday, December 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $26.88.
Healthcare Realty Trust Price Performance
Healthcare Realty Trust Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Stockholders of record on Tuesday, March 7th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 6.67%. The ex-dividend date is Monday, March 6th. Healthcare Realty Trust’s payout ratio is 1,127.27%.
Healthcare Realty Trust Profile
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded in 1992 and is headquartered in Nashville, TN.
Recommended Stories
- Get a free copy of the StockNews.com research report on Healthcare Realty Trust (HR)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.